Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Survivor Perspectives on Artificial Intelligence Integration in Breast Cancer Treatment: A Qualitative Study of Trust, Equity, and Application.

European journal of breast health·2026
Same author

Pathogenic Germline Variants in a Racially Diverse Real-World Cohort of Patients With Prostate Cancer.

Journal of the National Comprehensive Cancer Network : JNCCN·2026
Same author

Gynecologic cancers in veterans and military service members compared to non-veterans, 2004-2021: A National cancer database study.

Gynecologic oncology reports·2026
Same author

Exploring the potential of postmastectomy radiotherapy in cN + and ypN0 breast cancer patients following neoadjuvant chemotherapy.

Breast cancer research and treatment·2026
Same author

Tumor-infiltrating lymphocyte therapy in metastatic vulvar melanoma: A case report and review of the literature.

Gynecologic oncology reports·2026
Same author

ACT-ON: Assisted cascade testing via outreach and navigation - Real-world experience with clinician-facilitated cascade testing.

Gynecologic oncology·2026

Related Experiment Video

Updated: Oct 13, 2025

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors
11:15

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

Published on: September 20, 2016

24.6K

Disparities in Genetic Testing for Heritable Solid-Tumor Malignancies.

Jacquelyn Dillon1, Foluso O Ademuyiwa2, Megan Barrett3

  • 1Department of Surgery, Duke University Medical Center, Durham, NC, USA.

Surgical Oncology Clinics of North America
|November 15, 2021
PubMed
Summary
This summary is machine-generated.

Genetic testing can save lives by identifying high-risk individuals. However, unequal access to this technology may worsen existing health disparities among different racial and ethnic groups.

Keywords:
DisparitiesGenetic testingGermline genetic testingHereditary cancer

More Related Videos

Comparative Lesions Analysis Through a Targeted Sequencing Approach
08:16

Comparative Lesions Analysis Through a Targeted Sequencing Approach

Published on: November 5, 2019

6.9K
Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

7.4K

Related Experiment Videos

Last Updated: Oct 13, 2025

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors
11:15

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

Published on: September 20, 2016

24.6K
Comparative Lesions Analysis Through a Targeted Sequencing Approach
08:16

Comparative Lesions Analysis Through a Targeted Sequencing Approach

Published on: November 5, 2019

6.9K
Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

7.4K

Area of Science:

  • Medical Genetics
  • Health Disparities Research
  • Oncology

Background:

  • Genetic testing is a vital tool for identifying individuals at high risk for certain conditions.
  • Consistent disparities in the utilization of genetic testing have been observed across different populations.
  • These disparities have significant implications for equitable healthcare delivery and patient outcomes.

Purpose of the Study:

  • To examine the role of genetic testing in potentially reducing health disparities.
  • To analyze the implications of unequal distribution of genetic testing in cancer care.
  • To explore the potential for genetic testing to either decrease or widen existing mortality gaps.

Main Methods:

  • Review of existing literature on genetic testing utilization.
  • Analysis of data on disparities in genetic testing access.
  • Comparative assessment of genetic testing's impact on different racial and ethnic groups.

Main Results:

  • Genetic testing, when equitably applied, holds potential for mitigating health inequities.
  • Disproportionate distribution of genetic testing in cancer care risks exacerbating existing disparities.
  • Unequal access may widen the mortality gap between racial and ethnic populations.

Conclusions:

  • Equitable implementation of genetic testing is crucial for its role in reducing health disparities.
  • Addressing disparities in genetic testing access is essential to prevent widening the mortality gap.
  • Genetic testing's potential to improve health equity is contingent upon its fair and widespread availability.